Neurobiological mechanisms in major depressive disorder

Marije Aan Het Rot; Sanjay J. Mathew; Dennis S. Charney

doi:10.1503/cmaj.080697

Neurobiological mechanisms in major depressive disorder

Marije Aan Het Rot, Sanjay J. Mathew, Dennis S. Charney

Research output: Contribution to journal › Review article › peer-review

337 Scopus citations

Original language	English
Pages (from-to)	305-313
Number of pages	9
Journal	CMAJ
Volume	180
Issue number	3
DOIs	https://doi.org/10.1503/cmaj.080697
State	Published - 3 Feb 2009

Access to Document

10.1503/cmaj.080697

Cite this

@article{bfd1e0ecb53c4f05b08dc4c68d7cf502,

title = "Neurobiological mechanisms in major depressive disorder",

author = "Rot, {Marije Aan Het} and Mathew, {Sanjay J.} and Charney, {Dennis S.}",

note = "Funding Information: Competing interests: Sanjay Mathew and Dennis Charney have been named as inventors on a use-patent of ketamine for the treatment of depression. Dennis Charney has received consulting fees from Unilever UK Central Resources Limited. Sanjay Mathew has received grant support from Alexza Pharmaceuticals, GlaxoSmithKline, Novartis and NARSAD, and he has received consulting or lecture fees from AstraZeneca and Jazz Pharmaceuticals. None declared for Marije aan het Rot. ",

year = "2009",

month = feb,

day = "3",

doi = "10.1503/cmaj.080697",

language = "English",

volume = "180",

pages = "305--313",

journal = "CMAJ",

issn = "0008-4409",

publisher = "Canadian Medical Association",

number = "3",

}

TY - JOUR

T1 - Neurobiological mechanisms in major depressive disorder

AU - Rot, Marije Aan Het

AU - Mathew, Sanjay J.

AU - Charney, Dennis S.

N1 - Funding Information: Competing interests: Sanjay Mathew and Dennis Charney have been named as inventors on a use-patent of ketamine for the treatment of depression. Dennis Charney has received consulting fees from Unilever UK Central Resources Limited. Sanjay Mathew has received grant support from Alexza Pharmaceuticals, GlaxoSmithKline, Novartis and NARSAD, and he has received consulting or lecture fees from AstraZeneca and Jazz Pharmaceuticals. None declared for Marije aan het Rot.

PY - 2009/2/3

Y1 - 2009/2/3

UR - http://www.scopus.com/inward/record.url?scp=61449197838&partnerID=8YFLogxK

U2 - 10.1503/cmaj.080697

DO - 10.1503/cmaj.080697

M3 - Review article

C2 - 19188629

AN - SCOPUS:61449197838

SN - 0008-4409

VL - 180

SP - 305

EP - 313

JO - CMAJ

JF - CMAJ

IS - 3

ER -